یادداشتهای مربوط به کتابنامه ، واژه نامه و نمایه های داخل اثر
متن يادداشت
Includes bibliographical references and index.
یادداشتهای مربوط به مندرجات
متن يادداشت
Intro; Preface to the First Edition; Preface to the Second Edition; Contents; 1: Drug Interactions and Pharmacogenetics; 1.1 Introduction; 1.2 Principles of Drug Interactions; 1.2.1 Physical Interactions or Chemical Incompatibilities; 1.2.1.1 pH Effects; 1.2.1.2 Solubilizers; 1.2.1.3 Plasticizers; 1.2.1.4 Sorption; 1.2.2 Chemical Reactions; 1.2.3 Denaturation; 1.2.4 Pharmacokinetic Interactions; 1.2.4.1 Absorption; 1.2.4.2 Ionization; 1.2.5 Complexation; 1.2.5.1 Contact with the Digestive Mucosa; 1.2.5.2 Gastrointestinal Motility; Modifications in Drug Diffusion.
متن يادداشت
1.2.6 Binding to Plasma Proteins1.2.6.1 Modification of the Tissue Binding; Metabolic Interactions; Modifications in the Elimination; Miscellaneous; 1.2.7 Pharmacodynamic Interactions; 1.2.7.1 Terminology; 1.2.7.2 Synergy and Antagonism; 1.2.7.3 Enhancement and Antagonism; 1.3 Interactions Between Anticancer Drugs and Other Active Substances; 1.3.1 Antiemetics; 1.3.1.1 Chlorpromazine; 1.3.1.2 Metoclopramide; 1.3.1.3 Granisetron and Ondansetron; 1.3.2 Antiulcer Drugs; 1.3.3 Analgesics (Nonsteroidal Anti-inflammatory Drugs); 1.3.4 Antimicrobial Agents; 1.3.5 Miscellaneous.
متن يادداشت
1.4 Anticancer Drug-Anticancer Drug Interactions1.4.1 Modulation; 1.4.2 Undesired Drug Interactions; 1.5 Drug Interactions Between Anticancer Drugs and Resistance-Modifying Agents; 1.6 Pharmacogenetics; 1.7 Summary; References; 2: Breast Cancer; 2.1 Introduction; 2.2 Chemotherapy; 2.2.1 Classes of Chemotherapy and General Toxicities; 2.2.1.1 Anti-microtubule Agents (Taxanes, Ixabepilone, Eribulin, and Vinca Alkaloids); 2.2.1.2 Anthracyclines (Doxorubicin, Epirubicin, Mitoxantrone, Liposomal Doxorubicin, and Non-pegylated Liposomal Doxorubicin).
متن يادداشت
2.2.1.3 Antimetabolites (5-Fluorouracil, Methotrexate, Capecitabine, and Gemcitabine)2.2.1.4 Alkylating Agents (Cyclophosphamide, Cisplatin, and Carboplatin); 2.2.1.5 Dose-Dense Chemotherapy; 2.2.2 Incidence and Management of Selected Chemotherapy Toxicities; 2.2.2.1 Febrile Neutropenia; 2.2.2.2 Management of Chemotherapy-Induced Emesis; 2.2.2.3 Peripheral Neuropathy; 2.2.2.4 Cardiac Failure; 2.2.2.5 Gastrointestinal Side Effects: Mucositis, Diarrhea, and Constipation; 2.2.2.6 Cognitive Dysfunction; 2.2.2.7 Altered Body Image and Sexual Dysfunction; 2.2.2.8 Fertility.
Designed as a quick reference for oncologists, this handbook covers the side-effects of cancer therapy drugs, including chemotheraputic drugs. Organised by organ system, the text discusses treatment toxicity and side-effects, in addition to measures of prevention for each type of cancer therapy drug.
یادداشتهای مربوط به سفارشات
منبع سفارش / آدرس اشتراک
Springer Nature
شماره انبار
com.springer.onix.9783319702537
ویراست دیگر از اثر در قالب دیگر رسانه
عنوان
Side Effects of Medical Cancer Therapy : Prevention and Treatment.
شماره استاندارد بين المللي کتاب و موسيقي
9783319702520
موضوع (اسم عام یاعبارت اسمی عام)
موضوع مستند نشده
Cancer-- Chemotherapy-- Complications.
موضوع مستند نشده
Drugs-- Side effects.
موضوع مستند نشده
Antineoplastic Agents-- adverse effects.
موضوع مستند نشده
Drug Interactions.
موضوع مستند نشده
Drug-Related Side Effects and Adverse Reactions-- prevention & control.